Aligos Therapeutics Inc. (ALGS) Social Stream
ALIGOS THERAPEUTICS INC (ALGS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ALIGOS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 4 | $47 | $28 | $33.8 | $0.73 | 4530.14% |
| 2021-12-08 | 5 | $47 | $28 | $33.8 | $0.73 | 4530.14% |
| 2021-12-22 | 5 | $47 | $20 | $30.8 | $0.73 | 4119.18% |
| 2022-01-06 | 5 | $47 | $20 | $30.8 | $0.73 | 4119.18% |
| 2022-01-07 | 5 | $47 | $5 | $19.2 | $0.73 | 2530.14% |
| 2022-02-15 | 5 | $47 | $5 | $18.2 | $0.73 | 2393.15% |
| 2022-03-14 | 5 | $17 | $5 | $10.8 | $0.73 | 1379.45% |
| 2022-03-16 | 5 | $15 | $5 | $9.6 | $0.73 | 1215.07% |
| 2022-03-23 | 5 | $7 | $2.5 | $4.875 | $0.73 | 567.81% |
| 2022-04-01 | 5 | $11 | $2.5 | $6.1 | $0.73 | 735.62% |
| 2022-05-05 | 5 | $11 | $2 | $5.7 | $0.73 | 680.82% |
| 2022-08-04 | 5 | $11.001 | $2 | $4.9 | $0.73 | 571.23% |
| 2022-08-05 | 5 | $11.001 | $2 | $4.7 | $0.73 | 543.84% |
| 2022-08-08 | 5 | $5 | $1.2 | $2.74 | $0.73 | 275.34% |
| 2022-11-03 | 5 | $5 | $1.2 | $2.54 | $0.73 | 247.95% |
| 2023-01-06 | 5 | $5 | $1.2 | $2.84 | $0.73 | 289.04% |
| 2023-01-27 | 5 | $7 | $1.2 | $3.64 | $0.73 | 398.63% |
| 2023-02-08 | 4 | $7 | $1.2 | $3.3 | $0.73 | 352.05% |
| 2023-11-02 | 3 | $7 | $2 | $4 | $0.73 | 447.95% |
| 2023-12-15 | 3 | $7 | $1 | $3.666 | $0.73 | 402.19% |
The Trend in the Analyst Price Target
Over the past 16 months, ALGS's average price target has gone up $0.93.
Over the past 48 weeks, ALGS's average upside potential has been 211.2%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 5 | 7 | 1.2 | 3.640 | 1.890 | 92.59% |
| 2023-02-08 | 3 | 7 | 1.2 | 3.300 | 1.860 | 77.42% |
| 2023-07-19 | 3 | 7 | 2.0 | 4.000 | 1.000 | 300% |
| 2023-08-04 | 3 | 7 | 2.0 | 4.000 | 0.885 | 351.98% |
| 2023-12-15 | 3 | 7 | 1.0 | 3.666 | 0.585 | 526.67% |
ALGS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 2 | 0 | 1 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ALGS's average broker recommendation rating improved by 0 over the prior 31 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ALIGOS THERAPEUTICS INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1998.07% of that group.
- ALGS has a lower variance in analysts' estimates than -1825.33% of all US stocks.
- In terms of how ALIGOS THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is higher than 227.44% of that group.
- In the context of Healthcare stocks, ALIGOS THERAPEUTICS INC's number of analysts covering the stock is higher than 469.39% of them.
In the Pharmaceutical Products industry, SRZN, FDMT, and CGEM are the three stocks most similar to ALIGOS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ALGS using the data that counts. Try POWR Ratings for free.